Table 4 Baseline characteristics of the two groups with predicted increased and decreased mortality risk after the application of continuous kidney replacement therapy for the entire dataset.
Mortality, probability decreased | Mortality, probability increased | P* | |
|---|---|---|---|
Age (years) | 64.36 ± 0.23 | 58.90 ± 0.15 | < 0.001 |
Male (%) | 2365 (57.1) | 7005 (48.5) | < 0.001 |
Systolic blood pressure (mmHg) | 103.99 ± 0.31 | 122.32 ± 0.19 | < 0.001 |
Mean arterial pressure (mmHg) | 69.79 ± 0.27 | 81.04 ± 0.14 | < 0.001 |
Diastolic blood pressure (mmHg) | 54.93 ± 0.22 | 64.05 ± 0.13 | < 0.001 |
Heart rate (/min) | 101.50 ± 0.31 | 87.56 ± 0.16 | < 0.001 |
Respiratory rate (/min) | 23.10 ± 0.13 | 19.30 ± 0.05 | < 0.001 |
Oxygen saturation (%) | 93.05 ± 0.16 | 96.68 ± 0.04 | < 0.001 |
Fraction inspired oxygen | 0.30 ± 0.01 | 0.10 ± 0.00 | < 0.001 |
Body temperature (°C) | 36.63 ± 0.02 | 36.81 ± 0.01 | < 0.001 |
Urine output (ml/hr) | 37.60 ± 1.07 | 141.48 ± 1.50 | < 0.001 |
White blood cell (×10³/µL) | 17.46 ± 0.31 | 12.89 ± 0.30 | < 0.001 |
Hemoglobin (g/dL) | 10.53 ± 0.03 | 10.94 ± 0.02 | < 0.001 |
Platelet (×10³/µL) | 188.41 ± 2.31 | 233.96 ± 1.16 | < 0.001 |
Prothrombin time (sec) | 16.85 ± 0.17 | 14.61 ± 0.04 | < 0.001 |
pH | 7.12 ± 0.00 | 7.04 ± 0.00 | < 0.001 |
Anion gap (mmol/L) | 20.26 ± 0.11 | 13.76 ± 0.04 | < 0.001 |
Bicarbonate (mmol/L) | 17.03 ± 0.09 | 24.38 ± 0.05 | < 0.001 |
Sodium (mmol/L) | 137.95 ± 0.09 | 138.68 ± 0.05 | < 0.001 |
Potassium (mmol/L) | 4.63 ± 0.01 | 4.08 ± 0.01 | < 0.001 |
Albumin (mg/dL) | 2.58 ± 0.01 | 3.22 ± 0.01 | < 0.001 |
Total bilirubin (mg/dL) | 4.14 ± 0.14 | 1.31 ± 0.04 | < 0.001 |
Creatinine (mg/dL) | 2.88 ± 0.04 | 1.50 ± 0.02 | < 0.001 |
